Catalyst Wire Dossier Catalyst Wire Dossier

OMEGAVEN 10%

omega-3 fatty acid lipid emulsion
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OMEGAVEN 10%, covering 2016-03-30 to 2016-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of OMEGAVEN 10%® (n-3 EFA Lipid Emulsion) in Home Parenteral Nutrition-associated Liver Disease [NA]

See pricing